BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10945374)

  • 1. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.
    Adams ME; Lussier AJ; Peyron JG
    Drug Saf; 2000 Aug; 23(2):115-30. PubMed ID: 10945374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
    Adams ME
    J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA
    Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid.
    Nicholls M; Manjoo A; Shaw P; Niazi F; Rosen J
    Adv Ther; 2018 Apr; 35(4):523-530. PubMed ID: 29542009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-articular hyaluronan therapy.
    Marshall KW
    Curr Opin Rheumatol; 2000 Sep; 12(5):468-74. PubMed ID: 10990189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
    Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
    Adams ME; Atkinson MH; Lussier AJ; Schulz JI; Siminovitch KA; Wade JP; Zummer M
    Osteoarthritis Cartilage; 1995 Dec; 3(4):213-25. PubMed ID: 8689457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan or hylans for knee osteoarthritis?
    Drug Ther Bull; 1999 Sep; 37(9):71-2. PubMed ID: 10696690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints.
    Schiavinato A; Finesso M; Cortivo R; Abatangelo G
    Clin Exp Rheumatol; 2002; 20(4):445-54. PubMed ID: 12175098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosupplementation for osteoarthritis.
    Wright KE; Maurer SG; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2000 Feb; 29(2):80-8; discussion 88-9. PubMed ID: 10695858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis.
    Gigante A; Callegari L
    Rheumatol Int; 2011 Apr; 31(4):427-44. PubMed ID: 21113807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Allard S; O'Regan M
    Clin Ther; 2000 Jun; 22(6):792-5. PubMed ID: 10929925
    [No Abstract]   [Full Text] [Related]  

  • 14. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility study of different hyaluronan products for intra-articular treatment of knee osteoarthritis.
    Yoshioka K; Katayama M; Nishiyama T; Harada K; Takeshita S; Kawamata Y
    BMC Musculoskelet Disord; 2019 Sep; 20(1):424. PubMed ID: 31511072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
    Milas M; Rinaudo M; Roure I; Al-Assaf S; Phillips GO; Williams PA
    Biopolymers; 2001 Oct; 59(4):191-204. PubMed ID: 11473346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.
    Sun SF; Hsu CW; Lin HS; Liou IH; Chen YH; Hung CL
    J Bone Joint Surg Am; 2017 Mar; 99(6):462-471. PubMed ID: 28291178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
    Goldberg VM; Coutts RD
    Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee.
    Peck J; Slovek A; Miro P; Vij N; Traube B; Lee C; Berger AA; Kassem H; Kaye AD; Sherman WF; Abd-Elsayed A
    Orthop Rev (Pavia); 2021; 13(2):25549. PubMed ID: 34745480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.